PPT-AHRQ Pub. No. 20(22)-0036

March 2022 Decolonization of NonICU Patients With Devices Section 117 Nursing Protocol Training Nasal Mupirocin Targeted Decolonization Introduction Our hospital is adopting a targeted decolonization protocol for adult . ewer or 2007 Comparative Effectiveness Review. First Last, Credentials. Accreditation Statement. Physician Credit Designation Statement. PRIME Education, Inc. (PRIME®) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. . 32 Years at Rank Step Step Annual Monthly Annual Monthly Annual Monthly Annual Monthly 7,670.94,8127,901.0093,4207,785.0096,2408,020.00102,0968,508.00105,1328,761.00103,6208,635.00106,7168,893.00 * Ef Prepared for:. Agency for Healthcare Research and Quality (AHRQ). www.ahrq.gov. Introduction to recombinant activated factor VII (rFVIIa). Process for developing the comparative effectiveness review (CER). of . Medications . in the . Lived . E. xperience . of . Chronic . I. llness. Bruce L. Lambert, Ph.D.. Professor. Department of Pharmacy Administration. University of Illinois at . Chicago. lambertb@uic.edu. The Importance of Knowing When To Order Urine Cultures. AHRQ Pub. No. . 16(17)-. 0003-16-EF. March 2017. Upon completion of this training, participants will be able . to—. Explain why unnecessary urine cultures can lead to increases in catheter-associated urinary tract infection (CAUTI) reporting and resident harms. Courtney . Gidengil. , MD MPH. Peter Hussey, PhD. RAND Corporation. Overview. What . is the toolkit?. How . was the toolkit developed. ?. What . tools are in the toolkit? how can they be used for quality improvement at my hospital?. The Importance of Knowing When To Order Urine Cultures. AHRQ Pub. No. . 16(17)-. 0003-16-EF. March 2017. Upon completion of this training, participants will be able . to—. Explain why unnecessary urine cultures can lead to increases in catheter-associated urinary tract infection (CAUTI) reporting and resident harms. Andrew . B. . Bindman. , M.D.. Director, Agency for Healthcare Research and Quality. 1. State University System of Florida. Fourth Annual C.W. Bill Young Federal R&D Agency Workshop. Washington, D.C.. Safe Medication Administration. AHRQ Publication No. 17-0003-19-EF. May. 2017. Learning Objectives. 2. AHRQ Safety Program for Perinatal Care. Safe Administration of Medications in L&D. The safe administration of two commonly used high-alert medications in labor and delivery (L&D) units is the focus of one customizable bundle within the . Quick-to Dissemination for Practice-Based Research NetworksOverviewThis document briefdescribesthe disseminationplanning and implementation process It contains links to resources that guideyou through Quality Indicators . Background for Hospital Board & Senior Leadership. . Understand the importance of the AHRQ Quality Indicators (QIs. ).. Understand the financial and clinical implications of the QIs for our . SOURCE: . AHRQ. , “National Healthcare Disparities Report, 2011, http://. www.ahrq.gov/qual/qrdr11.htm. Disparities in Access to Care for Selected Groups. Percent of access measures for which groups experienced worse, same, or better access to care:. Prepared for:. Agency for Healthcare Research and Quality (AHRQ). www.ahrq.gov. Introduction to recombinant activated factor VII (rFVIIa). Process for developing the comparative effectiveness review (CER).